Indirect comparisons of efficacy of zanubrutinib versus orelabrutinib in patients with relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma or relapsed or refractory mantle cell lymphoma
间接比较泽布替尼与奥拉替尼在复发或难治性慢性淋巴细胞白血病/小淋巴细胞淋巴瘤或复发或难治性套细胞淋巴瘤患者中的疗效
期刊:Investigational New Drugs
影响因子:2.7
doi:10.1007/s10637-023-01376-1
Song, Yuqin; Zhou, Keshu; Yang, Shenmiao; Hu, Jianda; Zou, Dehui; Gao, Sujun; Pan, Ling; Wang, Tingyu; Yang, Haiyan; Zhang, Huilai; Zhou, Daobin; Ji, Jie; Xu, Wei; Feng, Ru; Jin, Jie; Lv, Fangfang; Huang, Haiwen; Fan, Xiaosi; Xu, Sheng; Zhu, Jun
